CoreAge Rx · individual offer review

Compounded tirzepatide.

Advertised starting price. The help center describes multi-month plans; exact initial charge, strength and supply are confirmed during consultation. No separate membership is advertised; shipping is advertised as included. If treatment is declined, the help center describes a refund less a nonrefundable consultation fee of unverified amount.

Read the receipt.

Displayed amount
$129 /mo from
Delivery route
Injection
Product status
Compounded prescription
Membership in this figure
See provider inclusions and terms
Quantity
Confirm the exact supplied quantity
Upfront commitment
Confirm the initial charge and billing period
Price basis
Publisher-supplied price update, October 9, 2026. Linked public page still showed an older amount at check.

Confirm taxes, diagnostics and any costs not specified in the quote.

Sources: CoreAge Rx — Compounded tirzepatide, CoreAge Rx — product and plan terms, FDA — compounding questions and answers

What this price means.

The $129 headline can be a useful starting point for a consultation quote. It should not be compared to a Zepbound price without acknowledging that the products have different approval status. Request the preparation, pharmacy, quantity and billing period rather than assuming an approved brand is being dispensed.

Sources: CoreAge Rx — Compounded tirzepatide, CoreAge Rx — product and plan terms, FDA — compounding questions and answers

The product context.

Zepbound is an FDA-approved tirzepatide medicine. Its approved uses and contraindications are defined in its prescribing information. A compounded preparation has not undergone FDA approval. Manufacturer offers for one device cannot be assumed to apply to another device or to every insurance situation.

Sources: Zepbound — prescribing information, FDA — concerns with unapproved GLP-1 drugs

Before you pay.

What will actually be charged today?

Confirm the initial charge and billing period. Request the full amount due today, its supply period, the next charge date and the renewal amount. The displayed price is a sourced offer, not a personalized invoice.

Is this a clinical recommendation?

No. This review covers public product and price information. Eligibility, treatment choice and the prescribed amount require an appropriate clinician. We have not tested this product.

What should I compare it with?

Start with the same ingredient, route, supplied quantity and billing term. Add any separate care or membership fees. Differences in product approval or formulation remain meaningful even when prices are similar.

Follow the evidence

Sources & price notes

Each source retains its own check date. Provider pages document advertised terms; they do not independently establish clinical outcomes.

  1. CoreAge Rx — Compounded tirzepatide ↗

    Price updated by the publisher October 9, 2026. The linked public product page still displayed an older amount when checked; confirm the current plan and initial commitment directly.

    Checked October 9, 2026

  2. CoreAge Rx — product and plan terms ↗

    Official product catalog and plan terms rechecked October 9, 2026.

    Checked October 9, 2026

  3. FDA — compounding questions and answers ↗

    Clinical and regulatory context. A compounded preparation is not FDA-approved.

    Checked October 8, 2026

  4. Zepbound — prescribing information ↗

    Approved uses, contraindications and warnings.

    Checked October 8, 2026

  5. FDA — concerns with unapproved GLP-1 drugs ↗

    Safety, dosing errors, salt forms and misleading online marketing. Regulatory page rechecked October 9, 2026; retain distinctions between approval, risk information and compounding nominations.

    Checked October 9, 2026